We Bring Innovation to Healthcare
Antiphospholipid Syndrome
Antiphospholipid Syndrome (APS), also known as Hughes syndrome is an autoimmune disease defined by the development of venous and/or arterial thrombosis, often multiple, and pregnancy morbidity.
Pipeline
Endotelix is fully focused on innovation within the field of antiphospholipid syndrome. As such, our pipeline is centred on two main clinical developmental projects.
These projects, which include diagnostics and treatments, will significantly improve the management of APS and therefore the lives of the patients who suffer from it.
Products
Endotelix offers fast, reliable and specific solutions for clinical APS management, including diagnostic tools and treatments.
ABOUT US
Endotelix is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Endotelix is dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome including diagnostic tests and treatment options.
...........
CONTACT US
Endotelix Diagnostics Sàrl
Chemin des Aulx, 14
CH-1228 Plan-les-Ouates
Tel: +41 (0)22 880 1010
Geneva, Switzerland